SUPERNUS PHARMACEUTICALS INC

CUSIP: 868459AD0 Class: NOTE

Radcliffe Capital Management, L.P.'s Holding History (CIK: 0001218275)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 90,815,000 Value ($000) $90,803 Avg Close — Range —
Q4 2022
Shares 69,010,000 Value ($000) $67,802 Avg Close — Range —
Q3 2022
Shares 69,010,000 Value ($000) $66,940 Avg Close — Range —
Q2 2022
Shares 69,010,000 Value ($000) $66,983 Avg Close — Range —
Q1 2022
Shares 69,010,000 Value ($000) $67,673 Avg Close — Range —
Q4 2021
Shares 69,010,000 Value ($000) $68,018 Avg Close — Range —
Q3 2021
Shares 69,010,000 Value ($000) $67,802 Avg Close — Range —
Q2 2021
Shares 58,708,000 Value ($000) $57,717 Avg Close — Range —
Q1 2021
Shares 58,877,000 Value ($000) $56,759 Avg Close — Range —
Q4 2020
Shares 58,877,000 Value ($000) $55,835 Avg Close — Range —
Q3 2020
Shares 41,266,000 Value ($000) $38,009 Avg Close — Range —
Q2 2020
Shares 29,830,000 Value ($000) $26,252 Avg Close — Range —
Q1 2020
Shares 12,749,000 Value ($000) $10,237 Avg Close — Range —